EUVIMEDEUVIMED entdecken
Crossref

Effect of Intravitreal Aflibercept on Corneal Endothelial Cells

Zuzana Šulavíková, Zuzana Šustykevičová, Marek Káčerik, Vladimír Krásnik

Czech and Slovak Ophthalmology · 2024

DOI: 10.31348/2024/18 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Czech and Slovak Ophthalmology, 2024. Verfasst von Zuzana Šulavíková und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To determine the effect of repeated intravitreal injections of aflibercept on the corneal endothelium in patients with diabetic macular edema (DME) and macular edema due to retinal vein occlusion (RVO).

Methods

In a prospective study conducted between January 2021 and November 2023, a total of 87 treatment-naive eyes with DME and RVO were evaluated. The exclusion criteria were surgery or laser intervention during the follow-up period, contact lens wear, cataract surgery in the last 6 months, dystrophy, or other corneal condition that may cause endothelial damage. In addition to routine examinations on the day of application, we also measured the corneal endothelium using specular microscopy on the 1st, 4th and 8th day of injection. We evaluated 4 parameters: endothelial cell density (CD), hexagonality (HEX), coefficient of variability (CV) and central corneal thickness (CCT). First of all, we evaluated the entire cohort of eyes, and then divided it according to 2 criteria; the diagnosis into DME/RVO and according to the lens status into phakic/pseudophakic eyes.

Results

A total of 87 eyes of 68 patients were evaluated. The average age of the patients at the time of diagnosis was 66.8 ±9.3 years. Within the cohort 51 (59%) eyes were phakic and 36 (41%) pseudophakic. A total of 61 (70%) eyes with a diagnosis of DME were treated, and 26 (30%) with RVO. During the follow-up, there were no significant changes in the average values of CD, HEX, CV, CCT due to aflibercept treatment, either in the whole group or in subgroups according to diagnosis or lens condition.

Conclusions

The results of this study suggest that intravitreal administration of aflibercept in patients with DME and RVO did not have an impact on corneal endothelial parameters, including CCT, HEX, CD and CV. These parameters were measured using endothelial microscopy during an 8-injection observation period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macular EdemaDiabetic RetinopathyRetinal Vein OcclusionHumansMiddle AgedAgedEndothelial CellsProspective StudiesReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsIntravitreal InjectionsAngiogenesis Inhibitors

Stichwörter der Autor:innen

Endothelial cellsafliberceptantiVEGFcorneal endotheliumspecular microscope

Substanzen

afliberceptReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsAngiogenesis Inhibitors

Zitieren

APA

Šulavíková, Z., Šustykevičová, Z., Káčerik, M., & Krásnik, V. (2024). Effect of Intravitreal Aflibercept on Corneal Endothelial Cells. Czech and Slovak Ophthalmology. https://doi.org/10.31348/2024/18

Vancouver

Šulavíková Z, Šustykevičová Z, Káčerik M, Krásnik V. Effect of Intravitreal Aflibercept on Corneal Endothelial Cells. Czech and Slovak Ophthalmology. 2024. doi:10.31348/2024/18

BibTeX
@article{ulavkov2024,
  author = {Šulavíková, Zuzana and Šustykevičová, Zuzana and Káčerik, Marek and Krásnik, Vladimír},
  title = {Effect of Intravitreal Aflibercept on Corneal Endothelial Cells},
  journal = {Czech and Slovak Ophthalmology},
  year = {2024},
  doi = {10.31348/2024/18}
}
Kostenlos starten →